niludipine , a ca2+-antagonist of the dihydropyridine derivatives , was administered to 50 patients , 27 with effort angina pectoris , 4 with rest angina , 7 with effort plus rest angina , 4 with variant angina , 8 with angina following myocardial infarction in the doses of 60 mg/day or 120 mg/day for 4 weeks and the changes of subjective symptoms and objective findings were evaluated .
C0002965
rest angina
C0002962
angina